Estimation of brain amine metabolism in affective illness: cerebrospinal fluid studies utilizing probenecid.
D001714:Bipolar Disorder / Q000134:cerebrospinal fluid* / Q000188:drug therapy; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D003863:Depression / Q000134:cerebrospinal fluid* / Q000188:drug therapy; D004295:Dihydroxyphenylalanine / Q000494:pharmacology / Q000627:therapeutic use; D010134:Fenclonine / Q000494:pharmacology / Q000627:therapeutic use; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid*; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid*; D008781:Methyltyrosines / Q000494:pharmacology / Q000627:therapeutic use; D010648:Phenylacetates / Q000134:cerebrospinal fluid*; D010919:Placebos; D011339:Probenecid / Q000494:pharmacology*; D013268:Stimulation, Chemical; D019966:Substance-Related Disorders / Q000134:cerebrospinal fluid*; D014364:Tryptophan / Q000494:pharmacology / Q000627:therapeutic use
D008781:Methyltyrosines; D010648:Phenylacetates; D010919:Placebos; D006897:Hydroxyindoleacetic Acid; D004295:Dihydroxyphenylalanine; D014364:Tryptophan; D011339:Probenecid; D010134:Fenclonine; D006719:Homovanillic Acid